跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
embryonic stem cell therapy
首页
药物
embryonic stem cell therapy
embryonic stem cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Embryonic stem cell-derived cardiomyocytes and cell therapy product using same as active ingredient
申请人: CHABIO & DIOSTECH CO LTD
优先权: 2011
CN
Human embryonic stem cell methods and PODXL expression
申请人: CHOO ANDRE
优先权: 2007
US
4 件公开
METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS USING MICROVESICLES DERIVED FROM EMBRYONIC STEM CELLS
申请人: PARK JAE-SUNG
优先权: 2011
CN
US
2 件公开
Method for preparing anti-colon cancer medicine by using carcino-embryonic antigen to stimulate embryonic stem cells
申请人: UNIV CHONGQING MEDICAL
优先权: 2023
CN
Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants
申请人: HANNOVER MED HOCHSCHULE
优先权: 2003
EP
US
2 件公开
Composition and method for differentiation of human embryonic stem cells
申请人: BONE HEATHER K
优先权: 2009
CN
US
3 件公开
Method for removing undifferentiated pluripotent stem cells
申请人: LU JOYCE JEAN
优先权: 2018
US
Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Oct4 in combination with Bmi1 or its upstream regulator, and method for generating induced pluripotent stem cells using the same
申请人: UNIV KOREA RES & BUS FOUND
优先权: 2009
EP
US
4 件公开
药物
反馈